Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definition
1.3 Base estimates & calculations
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Dry eye disease industry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Product trends
2.5 Disease type trends
2.6 Distribution channel trends
Chapter 3 Dry Eye Disease Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of eye-related diseases
3.2.1.2 Rising awareness associated with dry eye syndrome
3.2.1.3 Technological advancements in dry eye disease treatment products
3.2.1.4 Growing geriatric population base
3.2.2 Industry pitfalls & challenges
3.2.2.1 Lack of skilled ophthalmologists
3.2.2.2 High cost of products
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By disease type
3.3.3 By distribution channel
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.6 Key market trends
3.7 Reimbursement scenario
3.8 Technology landscape
3.9 Future market trends
3.10 Value chain analysis
3.11 Gap Analysis
3.12 Porter's analysis
3.13 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Vendor matrix analysis
4.5 Competitive positioning matrix
4.6 Strategy dashboard, 2022
Chapter 5 Dry Eye Disease Market Size and Forecast, By Product (USD Million)
5.1 Key trends, by product
5.2 Cyclosporine
5.3 Topical corticosteroids
5.4 Artificial tears
5.5 Punctal plugs
5.5.1 Removable
5.5.2 Dissolvable
5.6 Oral omega supplements
5.7 Others
Chapter 6 Dry Eye Disease Market Size and Forecast, By Disease Type (USD Million)
6.1 Key trends, by disease type
6.2 evaporative dry eye syndrome
6.3 aqueous deficient dry eye syndrome
Chapter 7 Dry Eye Disease Market Size and Forecast, By Distribution Channel (USD Million)
7.1 Key trends, by distribution channel
7.2 Hospital pharmacy
7.3 Retail pharmacy
7.4 Online pharmacy
Chapter 8 Dry Eye Disease Market Size and Forecast, By Region (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Poland
8.3.7 Sweden
8.3.8 The Netherlands
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Thailand
8.4.7 Indonesia
8.4.8 Philippines
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Columbia
8.5.5 Chile
8.5.6 Peru
8.6 MEA
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Israel
8.6.5 Egypt
8.6.6 Turkey
Chapter 9 Company Profiles
9.1 AbbVie, Inc.
9.2 AFT Pharmaceuticals
9.3 Alcon
9.4 Bausch & Lomb
9.5 Johnson & Johnson Services, Inc.
9.6 Novartis AG
9.7 OASIS Medical
9.8 Otsuka Pharmaceutical Co., Ltd.
9.9 Oyster Point Pharma, Inc.
9.10 Santen Pharmaceutical Co., Ltd.
9.11 Sentiss Pharma Pvt. Ltd
9.12 Sun Pharmaceutical Industries Ltd.
9.13 Thea Pharmaceuticals Ltd.
9.14 VISUfarma
9.15 Takeda Pharmaceutical Company Ltd.
